NCT02774226View on ClinicalTrials.gov

Long Term Nitric Oxide Bioavailability on Vascular Health in Chronic Obstructive Pulmonary Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

July 30, 2018

Study Completion Date

July 30, 2018

Conditions
Chronic Obstructive Pulmonary Disease (COPD)
Interventions
DRUG

Tetrahydrobiopterin (BH4)

12 week intervention

DIETARY_SUPPLEMENT

Antioxidant Cocktail

12 week intervention

Trial Locations (1)

30912

Georgia Prevention Institute, Augusta

All Listed Sponsors
lead

Augusta University

OTHER

NCT02774226 - Long Term Nitric Oxide Bioavailability on Vascular Health in Chronic Obstructive Pulmonary Disease | Biotech Hunter | Biotech Hunter